Rhumbline Advisers »

Eyepoint Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 46k 23.11
2023-09-30 $334k 42k 7.99
2023-06-30 $352k 40k 8.70
2023-03-31 $115k 39k 2.93
2022-12-31 $132k 38k 3.50
2022-09-30 $296k 38k 7.90
2022-06-30 $278k 35k 7.87
2022-03-31 $358k 30k 12.15
2021-12-31 $270k 22k 12.26
2021-09-30 $229k 22k 10.40
2021-06-30 $186k 21k 9.01